Clinical-Stage Biopharmaceutical Company with Novel Targeted Therapy for Brain Tumors
Location: TX
Date: February 6, 2024
This listing represents a clinical-stage biopharmaceutical company focused on developing a novel, patented small-molecule therapeutic agent for brain cancers,